Trial Profile
A Multi-center, Randomized, Multiple-dose, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Abuse-deterrent Immediate-release Capsules Oxycodone Hydrochloride, Naltrexone Hydrochloride 1.5 mg or Oxycodone Hydrochloride, Naltrexone Hydrochloride 3.0 mg for the Treatment of Adults With Moderate to Severe Pain Following Bunionectomy Surgery
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Oct 2015
Price :
$35
*
At a glance
- Drugs Oxycodone/naltrexone (Primary)
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- Sponsors Elite Laboratories
- 21 Oct 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 23 Jul 2015 Planned End Date changed from 1 Jul 2015 to 1 Aug 2015 as reported by ClinicalTrials.gov.
- 23 Jul 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.